Skip to main content

Table 1 Baseline characteristics of the cohort

From: The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients

  Global
n=100
n (%) or median [p25;p75]
Sociodemographic data
 Sex
  Female 63 (63.0%)
  Male 37 (37.0%)
 Age, years 76.0 [73.0;80.0]
 BMI, kg·m−2 27.6 [25.1;30.6]
 Education, years 7.00 [7.00;7.00]
Comorbidities
 Hypertension 59 (59.0%)
 Diabetes mellitus 20 (20.0%)
 Cardiopathy 21 (21.0%)
 Depression 28 (28.3%)
 Periodic limb movements 44 (49.4%)
Cognition
 MMSE 23.5 [22.0;25.0]
CSF biomarkers
 Aβ42, pg/ml 533 [402;669]
 T-tau, pg/ml 464 [330;598]
 P-tau, pg/ml 72.3 [53;93]
Genetic risk
 ApoEε4− 41 (41.8%)
  1. ApoEε4− apolipoprotein E carrier, Aβ42 amyloid-beta protein, BMI body mass index, CSF cerebrospinal fluid, MMSE Mini-Mental State Examination, n number, p percentile, P-tau phosphorylated-tau, T-tau total-tau. Missings: Depression, 1; Periodic limb movements, 11; CSF biomarkers, 10; ApoEε4−, 2